Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
41,135,969
-
Share change
-
-325,277
-
Total reported value
-
$3,622,553,098
-
Put/Call ratio
-
90%
-
Price per share
-
$88.08
-
Number of holders
-
306
-
Value change
-
-$14,393,169
-
Number of buys
-
143
-
Number of sells
-
130
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2019
As of 31 Dec 2019,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
306 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,135,969 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, Palo Alto Investors LP, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., and Consonance Capital Management LP.
This page lists
309
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.